Apr 25, 2022, 17:17 by

Rho Appoints Peter Schmidt, Ph.D., as SVP, Government Partnerships, Executive Committee Member Former Vice Dean at East Carolina University’s Brody School of Medicine brings scientific and strategic expertise to lead the federally funded clinical research enterprise of this international CRO. Research Triangle Park, NC – April 19, 2022 – Rho, a global full-service contract research organization (CRO) with a proven track record of drug development success, has appointed Peter Schmidt, Ph.D., as Senior Vice President, Government Partnerships of Rho’s Federal Systems Division. For over 30 years, Rho has worked closely with NIH/NIAID and other federal departments on groundbreaking clinical trial and epidemiologic studies, including the LEAP peanut allergy study. “I am thrilled to welcome Dr. Schmidt to Rho," said Dr. Laura Helms Reece, CEO, Rho. “He is a preeminent neuroscientist and recognized leader across federal, commercial and academic arenas. His expertise in clinical research is remarkable, and his command of central nervous system, infectious disease, and other indications is a great fit with Rho’s focus in those areas. I am eager to work with Dr. Schmidt as he brings exciting strategic and scientific leadership to our federal business. His experience and judgment will be great additions to our Executive Committee.”

Apr 25, 2022, 17:17 by

Apr 25, 2022, 17:17 by

Creative Peptides constructed a versatile total peptide library with its proprietary peptide design platform to accelerate peptide drug research.

Apr 25, 2022, 17:17 by

BOC Sciences unveils its comprehensive custom synthesis services for worldwide partners engaged in biopharmaceutical, chemical, and life science research.

Apr 25, 2022, 17:17 by

List Bio will use an $48.4 million Series A investment to build a large-scale manufacturing facility in Fishers, Indiana, USA

Apr 25, 2022, 17:17 by

Panthera Biopartners has secured £10 million of investment from BGF and Gresham House Ventures, the latter investing on behalf of the Baronsmead VCTs. This investment round will be used to fund further expansion in the UK and Western Europe.

Apr 25, 2022, 17:17 by

Apr 25, 2022, 17:17 by

Rho Experts Share How Customized Data Visualization Platform Provides Sponsors Real-time Study Data to Inform Decisions Global CRO to demonstrate how data visualization can improve the conduct of clinical trials in a free webinar WHAT: Rho, a global full-service contract research organization (CRO) with a proven track record of drug development success, will discuss how ongoing access to real-time clinical study data and metrics is essential for efficient start-up and conduct of clinical trials in an upcoming webinar, “Using Advanced Data Visualization to Power Up Clinical Trials.” The webinar will take place on Wednesday, April 27, from 2-3 p.m. EST.

Apr 25, 2022, 17:17 by

Apr 25, 2022, 17:17 by

For more information on Tower Cold Chain, visit https://bit.ly/3MicrTr

Apr 25, 2022, 17:17 by

Sweden-based NorthX Biologics (“NorthX”), which focuses on process development and large-scale production of advanced biological drugs, has signed a collaboration agreement with Abera Bioscience (“Abera”) for upscaling and GMP manufacturing of its vaccine candidate against pneumococcus, Ab-01.12.

Apr 25, 2022, 17:17 by

Curebase selected to launch a clinical investigation of a digital therapeutic for IPF

Apr 25, 2022, 01:00 by User Not Found

Clinical Research News | In a pragmatic clinical trial at a pair of health systems in New York City, researchers at the Mount Sinai Health System have determined that the full potential of genomics to improve clinical patient management may well depend on engaging community-based racial and ethnic minority groups in the effort. The National Institutes of Health is now funding a large, comprehensive nationwide study (GUARDD-US) through the Implementing Genomics in Practice (IGNITE) network aimed both at changing health behaviors and making pharmacogenomics-based treatment recommendations.

Apr 22, 2022, 10:41 by User Not Found

Clinical Research News | While most medicines are derived from chemical compound, biologics are now the fastest-growing drug class. To deliver these complex drugs to patients as quickly as possible, the biopharmaceutical industry is shifting away from traditional batch processing to continuous bioprocessing.

Apr 19, 2022, 01:00 by User Not Found

Clinical Research News | A blood test to help clinicians diagnose Alzheimer’s disease is “on the road” to effectively replacing cerebrospinal fluid (CSF) testing and PET scans for detecting Alzheimer’s pathology, according to Randall J. Bateman, M.D., a professor of neurology at Washington University School of Medicine and co-developer of the plasma protein assay. A commercial version of the test, PrecivityAD, is already being used extensively in clinical trials as well to evaluate patients in real-world settings.

Apr 14, 2022, 18:52 by

Apr 14, 2022, 18:52 by

Apr 14, 2022, 18:52 by

CluePoints Wins Citeline Award for Excellence in Innovation in Response to COVID-19 - Clinical Trial Activities Company wins prestigious accolade for contribution to Pfizer/BioNTech BNT162b2 COVID-19 vaccine development King of Prussia, PA – April 11, 2022: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has won the Citeline Award for Excellence in Innovation in Response to COVID-19 – Clinical Trial Activities.

Apr 14, 2022, 18:52 by

Jennifer has more than 16 years’ commercial leadership experience in the diagnostics and life sciences industries.

Apr 14, 2022, 18:52 by

Ripple Enterprise software to be deployed as part of the digital transformation in clinical trials spearheaded by Curavit.